VANESSA CROSSON: Open Payments
NPI 1770164907 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,015 in 104 payments from 24 companies in 2025. Trend: 2023 $2,361 · 2024 $2,879 · 2025 $2,015
Food & beverage: $2,015
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $331 |
| Lilly USA, LLC | 17 | $258 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $165 |
| Sumitomo Pharma America, Inc. | 7 | $163 |
| PFIZER INC. | 7 | $154 |
| ABBVIE INC. | 8 | $143 |
| Novartis Pharmaceuticals Corporation | 4 | $124 |
| Amgen Inc. | 5 | $101 |
| Merck Sharp & Dohme LLC | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $67 |
Products named: Ozempic, MOUNJARO, TRINTELLIX, GEMTESA, QULIPTA, LEQVIO, NURTEC ODT, EVENITY.
Industry payments across TX — which companies pay providers there.
